GlassScriptPhysician profile
Amy E Gonzales
NPI 1881831972
$2,854.08
in general payments reported to CMS, 2019-2025
41 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $370 · 2022: $1,067 · 2023: $799 · 2024: $348 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $526.15 | 2021-2024 | |
| Axsome Therapeutics, INC. | $205.56 | 2023-2025 | Sunosi, Auvelity |
| Lundbeck LLC | $162.12 | 2022-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $151.57 | 2022-2023 | Spravato |
| Alkermes, INC. | $117.59 | 2022-2023 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $109.95 | 2022-2023 | Ingrezza |
| Amgen INC. | $99.24 | 2021-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $92.53 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.33 | 2022 | |
| Ironshore Pharmaceuticals INC. | $85.56 | 2022-2023 | Jornay Pm |
| Zoll Respicardia, INC. | $85.52 | 2024 | Remede System |
| Acadia Pharmaceuticals INC | $84.11 | 2021-2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $80.60 | 2022-2025 | |
| Pfizer INC. | $74.03 | 2024-2025 | |
| Bausch Health US, LLC | $72.07 | 2022-2023 | Aplenzin |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.